Scholars Central

Conference abstractPublished 26 Nov 2018

Antigen-microarray profiling of antibodies in SLE: A personal view of translation from basic science to the clinic

Authors: Irun R Cohen

Weizmann Institute of Science, Rehovot, Israel

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In October of 2015, the startup company ImmunArray announced the launch of a microarray platformâ??the iChip® to profile repertoires of serum antibodies and autoantibodies. The first iChip® productâ??the SLE-key® Rule Out test is designed to help the physician rule out a diagnosis of systemic lupus erythematosus (SLE) in suspected patients. The aim of this review is threefold: the first aim is to describe how basic observations and a philosophical notion led the author to undertake the development of what has turned out to be a clinically useful aid in dealing with complex diseases; the second aim is to describe the role of a company in overcoming the technological and informatics challenges involved in translating basic research into patient welfare; the third aim is to discuss why SLE, like other complex medical problems, can be better managed using immune profiling. Basic scientist readers might learn here about the path to clinical application; clinician readers might learn here about the complicated origins of seemingly simple tests.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Irun R Cohen”